These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34374537)

  • 1. Synthesis and Biological Evaluation of Novel Triazine Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors.
    Wang X; Xiao H; Wang J; Huang Z; Peng G; Xie W; Bian X; Liu H; Shi C; Yang T; Li X; Gao J; Meng Y; Jiang Q; Chen W; Hu F; Wei N; Wang X; Zhang L; Wang K; Sun Q
    J Med Chem; 2021 Aug; 64(16):12379-12396. PubMed ID: 34374537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model.
    Sun LL; Yang TY; Wei NN; Lu W; Jiao WX; Zhou QQ; Miao YZ; Gao Q; Wang XT; Sun Q; Wang K
    Acta Pharmacol Sin; 2019 Jun; 40(6):737-745. PubMed ID: 30333556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
    Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
    J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 7 nicotinic receptor agonist and positive allosteric modulators improved social and molecular deficits of MK-801 model of schizophrenia in rats.
    Unal G; Bekci H; Cumaoglu A; Yerer MB; Aricioglu F
    Pharmacol Biochem Behav; 2020 Jun; 193():172916. PubMed ID: 32220620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Activation of α7 Nicotinic Acetylcholine Receptors by Novel 2-Arylamino-thiazole-5-carboxylic Acid Amide Derivatives for the Improvement of Cognitive Deficits in Mice.
    Yang C; Meng Y; Wang X; Li X; Yu T; Liao W; Xie W; Jiang Q; Wang H; Shi C; Jiao W; Bian X; Hu F; Wang X; Liu Y; Zhang L; Wang K; Sun Q
    J Med Chem; 2024 Apr; 67(8):6344-6364. PubMed ID: 38393821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats.
    Unal G; Sirvanci S; Aricioglu F
    Behav Brain Res; 2021 Jan; 397():112946. PubMed ID: 33011186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization.
    Verma MK; Goel RN; Bokare AM; Dandekar MP; Koul S; Desai S; Tota S; Singh N; Nigade PB; Patil VB; Modi D; Mehta M; Gundu J; Walunj SS; Karche NP; Sinha N; Kamboj RK; Palle VP
    Eur J Pharmacol; 2021 Jan; 891():173685. PubMed ID: 33127363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V
    J Psychopharmacol; 2019 Jun; 33(6):688-699. PubMed ID: 30920339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker.
    Hashimoto K
    Curr Pharm Des; 2015; 21(26):3797-806. PubMed ID: 26044974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Agonism of
    Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
    Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice.
    Li Y; Sun L; Yang T; Jiao W; Tang J; Huang X; Huang Z; Meng Y; Luo L; Wang X; Bian X; Zhang F; Wang K; Sun Q
    J Med Chem; 2019 Jan; 62(1):159-173. PubMed ID: 29587480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review.
    Antonio-Tolentino K; Hopkins CR
    Expert Opin Investig Drugs; 2020 Jun; 29(6):603-610. PubMed ID: 32396418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
    Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    Jones C
    J Clin Psychopharmacol; 2018 Jun; 38(3):247-249. PubMed ID: 29505470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
    Beinat C; Banister SD; Herrera M; Law V; Kassiou M
    CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
    Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
    Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
    Stevens KE; Zheng L; Floyd KL; Stitzel JA
    Brain Res; 2015 Jun; 1611():8-17. PubMed ID: 25744161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B.
    Tang JS; Xie BX; Bian XL; Xue Y; Wei NN; Zhou JH; Hao YC; Li G; Zhang LR; Wang KW
    Acta Pharmacol Sin; 2015 Jul; 36(7):800-12. PubMed ID: 25948478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.